Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013

Preventing metastases by tackling exosomes

Dr Jeff Wrana - University of Toronto, Canada
Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )
19 Dec 2013

Where next for chronic lymphocytic leukaemia in the elderly?

Prof Clemens Wendter, Prof Florence Cymbalista, Prof Anders Österborg
Where next for chronic lymphocytic leukaemia in the elderly? ( Prof Clemens Wendter, Prof Florence Cymbalista, Prof Anders Österborg )
19 Dec 2013

Moving breast cancer stem cell therapies to the clinic

Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013

A new trial alters therapy landscape in multiple myeloma

Prof Philippe Moreau - University Hospital Hôtel-Dieu, Nantes, France and Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
A new trial alters therapy landscape in multiple myeloma ( Prof Philippe Moreau - University Hospital Hôtel-Dieu, Nantes, France and Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
19 Dec 2013

Breast cancer psychosocial and survivorship issues: are we doing better?

Dr Lesley Fallowfield - University of Sussex, Brighton, UK
Breast cancer psychosocial and survivorship issues: are we doing better? ( Dr Lesley Fallowfield - University of Sussex, Brighton, UK )
19 Dec 2013

Male breast cancer: Opportunities for increased research funding and clinical trial access

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
Male breast cancer: Opportunities for increased research funding and clinical trial access ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Dr Sibylle Loibl - German Breast Cancer Group
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )
19 Dec 2013

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands
Where to next for the elderly with acute myeloid leukaemia? ( Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands )
19 Dec 2013

Exciting new developments in the treatment of multicentric Castleman disease

Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong
Exciting new developments in the treatment of multicentric Castleman disease ( Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong )
19 Dec 2013

Adjuvant bisphosphonate therapy in breast cancer

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant bisphosphonate therapy in breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
19 Dec 2013